Correlation Between AstraZeneca PLC and Medican Enterprises

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Medican Enterprises at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Medican Enterprises into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Medican Enterprises, you can compare the effects of market volatilities on AstraZeneca PLC and Medican Enterprises and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Medican Enterprises. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Medican Enterprises.

Diversification Opportunities for AstraZeneca PLC and Medican Enterprises

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between AstraZeneca and Medican is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Medican Enterprises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medican Enterprises and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Medican Enterprises. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medican Enterprises has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Medican Enterprises go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Medican Enterprises

Considering the 90-day investment horizon AstraZeneca PLC is expected to generate 386.25 times less return on investment than Medican Enterprises. But when comparing it to its historical volatility, AstraZeneca PLC ADR is 382.24 times less risky than Medican Enterprises. It trades about 0.36 of its potential returns per unit of risk. Medican Enterprises is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Medican Enterprises on November 3, 2024 and sell it today you would earn a total of  0.01  from holding Medican Enterprises or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  Medican Enterprises

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AstraZeneca PLC is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Medican Enterprises 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Medican Enterprises are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent fundamental indicators, Medican Enterprises displayed solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC and Medican Enterprises Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Medican Enterprises

The main advantage of trading using opposite AstraZeneca PLC and Medican Enterprises positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Medican Enterprises can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medican Enterprises will offset losses from the drop in Medican Enterprises' long position.
The idea behind AstraZeneca PLC ADR and Medican Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Content Syndication
Quickly integrate customizable finance content to your own investment portal